/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic.
/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic.
/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 11 abstracts highlighting data from its pulmonary hypertension (PH).